Psychopharmacologic strategies for the prevention of suicidal behavior in bipolar patients

Clinical Neuroscience Research

Volumn 1, Issue 5, 2001, Pages 387-393

  Oquendo, Maria A ^a   Barrera, Andres ^a   Mann, J John ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Anticonvulsants; Antipsychotics; Bipolar disorder; Lithium; Pharmacotherapy; Suicidal behavior

Indexed keywords

EID: 0038068817     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(01)00042-1     Document Type: Review

References (96)

1. Black DW, Winokur G, Nasrallah A. Suicide on subtypes of major affective disorder. A comparison with general population suicide mortality. Arch Gen Psychiatry 1987;44:878-880.
2. Chen Y-W, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry 1996;39:896-899.
3. Goodwin FK, Jamison KR. Suicide in manic-depressive illness. New York: Oxford University Press, 1990.
4. Axelsson R, Lagerkvist-Briggs M. Factors predicting suicide in psychotic patients. Eur Arch Psychiatry Clin Neurosci 1992;241:259-266.
5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Huges M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
6. Weissman MM, Bruce ML, Leaf PJ, Florio LP, Holzer C. Affective disorders in psychiatric disorders in America. In: Robins LN, Regier DA, editors. The Epidemiologic Catchment Area Study. New York: Free Press, 1998.
7. Rihmer Z, Barsi J, Arató M, Demeter E. Suicide in subtypes of primary major depression. J Affect Disord 1990;18:221-225.
8. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorder. Pharmacopsychiatry 1996;29:103-107.
9. Berglund M, Nilsson K. Mortality in severe depression. A prospective study including 103 suicides. Acta Psychiatr Scand 1987;76:372-380.
10. Black DW, Winokur G, Nasrallah A. Effect of psychosis on suicide risk in 1593 patients with unipolar and bipolar affective disorders. Am J Psychiatry 1988;145(7):849-852.
11. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-438.
12. Roy A. Features associated with suicide attempts in depression: a partial replication. J Affect Disord 1993;27:35-38.
13. Endicott J, Nee J, Andreasen N, Clayton P, Keller M, Coryell W. Bipolar II. Combine or keep separate? J Affect Disord 1985;8:17-28.
14. Coryell W, Andreasen NC, Endicott J, Keller M. The significance of past mania or hypomania in the course and outcome of major depression. Am J Psychiatry 1987;144:309-315.
15. Mann JJ, Waternaux C, Haas GL, Malone KM. Towards a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999;156:181-189.
16. Mann JJ, Arango V. Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 1992;12(2):2S-7S.
17. Cornelius JR, Salloum IM, Mezzich J, Cornelius MD, Fabrega Jr H, Ehler JG, Ulrich RF, Thase ME, Mann JJ. Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am J Psychiatry 1995;152:358-364.
18. Malone KM, Haas GL, Sweeney JA, Mann JJ. Major depression and the risk of attempted suicide. J Affect Disord 1995;34:173-185.
19. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. J Am Med Assoc 1985;254(7):915-918.
20. Roy A. Genetic and biologic risk factors for suicide in depressive disorders. Psychiatric Q 1993;64:345-358.
21. Schulsinger F, Kety SS, Rosenthal D, Wender PH. A family study of suicide. In: Schou M, Stromgren E, editors. Origin, prevention and treatment of affective disorders. New York: Academic Press, 1979.
22. Malone KM. Psychobiology of suicidal behavior in major depression, Galway: National University of Ireland, 1994. pp. 1-152.
23. Mann JJ, Malone KM, Sweeney JA, Brown RP, Linnoila M, Stanley B, Stanley M. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 1996;15:576-586.
24. Träskman-Bendz L, Alling C, Oreland L, Regnéll G, Vinge E, Öhman R. Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol 1992;12 Suppl:21S-26S.
25. Bulik CM, Carpenter LL, Kupfer DJ, Frank E. Features associated with suicide attempts in recurrent major depression. J Affect Disord 1990;18:29-37.
26. Corbitt EM, Malone KM, Haas GL, Mann JJ. Suicidal behavior in patients with major depression and comorbid personality disorders. J Affect Disord 1996;39:61-72.
27. Branchey L, Branchey M, Shaw S, Lieber CS. Depression, suicide, and aggression in alcoholics and their relationship to plasma amino acids. Psychiatry Res 1984;12:219-226.
28. Heikkinen M, Aro H, Lönnqvist J. Recent life events, social support and suicide. Acta Psychiatr Scand 1994;377:65-72.
29. Mann JJ, Malone KM, Underwood MD, Arango V. Clinical and neurobiological risk factors for suicidal behavior. In: Judd LL, Filip V, Basel SB, Karger S, editors. Basic and clinical science of mental and addictive disorders, Bibliography Psychiatry, vol. 167. 1997.
30. Duggan CF, Sham P, Lee AS, Murray RM. Can future suicidal behaviour in depressed patients be predicted. J Affect Disord 1991;22:111-118.
31. Lipe H, Schultz A, Bird TD. Risk factors for suicide in Huntington's disease: a retrospective case controlled study. Am J Med Genet 1993;48:231-233.
32. Mendez MF, Doss RC. Ictal and psychiatric aspects of suicide in epileptic patients. Int J Psychiatry Med 1992;22:231-237.
33. Stenager EN, Koch-Henriksen N, Stenager E. Risk factors for suicide in multiple sclerosis. Psychother Psychosom 1996;65:86-90.
34. Heikkinen ME, Isometsä ET, Marttunen MJ, Aro HM, Lönnqvist JK. Social factors in suicide. Br J Psychiatry 1995;167:747-753.
35. Boudewyn AC, Liem JH. Childhood sexual abuse as a precursor to depression and self- destructive behavior in adulthood. J Traumatic Stress 1995;8:445-459.
36. Deykin EY, Alpert JJ, McNamarra JJ. A pilot study of the effect of exposure to child abuse or neglect on adolescent suicidal behavior. Am J Psychiatry 1985;142:1299-1303.
37. Straus MA, Kantor GK. Corporal punishment of adolescents by parents: a risk factor in the epidemiology of depression suicide, alcohol abuse, child abuse, and wife beating. Adolescence 1994;29:543-561.
38. Beck AT. Hopelessness as a predictor of eventual suicide. Ann NY Acad Sci 1986;487:90-96.
39. Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 1990;147:190-195.
40. Beck AT, Steer RA, Kovacs M, Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985;142(5):559-563.
41. Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiatry 1987;144(1):35-40.
42. Rifai AH, George CJ, Stack JA, Mann JJ, Reynolds III CF. Hopelessness in suicide attempters after acute treatment of major depression in late life. Am J Psychiatry 1994;151:1687-1690.
43. Linehan MM, Goodstein JL, Nielsen SL, Chiles JA. Reasons for staying alive when you are thinking of killing yourself: the reasons for living inventory. J Consult Clin Psychol 1983;51:276-286.
44. Mann JJ. The neurobiology of suicide. Nat Med 1998;4:25-30.
45. Strakowski SM, McElroy SL, Keck Jr PE, West SA. Suicidality among patients with mixed and manic bipolar disorder. Am J Psychiatry 1996;153:674-676.
46. Dilsaver SC, Chen Y-W, Swann AC, Shoaib AM, Krajewski KJ. Suicidality in patients with pure and depressive mania. Am J Psychiatry 1994;151:1312-1315.
47. Isometsä ET, Henriksson MM, Aro HM, Lönnqvist JK. Suicide in bipolar disorder in Finland. Am J Psychiatry 1994;151:1020-1024.
48. Roy-Byrne PP, Post RM, Hambrick DD, Leverich GS, Rosoff AS. Sucide and course of illness in major affective disorder. J Affect Disord 1988;15:1-8.
49. Barraclough B, Bunch J, Nelson B, Sainsbury P. One hundred cases of suicide. Clinical aspects. Br J Psychiatry 1974;125:355-373.
50. Dorpat TL, Ripley HS. The relationship between attempted suicide and committed suicide. Compr Psychiatry 1967;8(2):74-79.
51. Hawton K, Fagg J, Platt S, Hawkins M. Factors associated with suicide after parasuicide in young people. BMJ 1993;306:1641-1644.
52. Powell J, Bradley B, Gray J. Classical conditioning and cognitive determinants of subjective craving for opiates: an investigation of their relative contributions. Br J Addiction 1992;87:1133-1144.
53. Ballenger JC, Goodwin FK, Major LF, Brown GL. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979;36:224-227.
54. Schmidtke A, Häfner H. The Werther effect after television films: new evidence for an old hypothesis. Psychol Med 1988;18:665-676.
55. Modestin J, Schwarzenbach F. Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatr Scand 1992;85:173-175.
56. Müller-Oerlinghausen B, Müser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992;225:261-270.
57. Ahrens B, Grof P, Möller HJ, Müller-Oerlinghausen B, Wolf T. Extended survival of patients on long-term lithium treatment. Can J Psychiatry 1995;40:241-246.
58. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord 1991;23:1-7.
59. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium. Pharmacopsychiatry 1995;28:8-13.
60. Norton B, Whalley LJ. Mortality of a lithium-treated population. Br J Psychiatry 1984;145:277-282.
61. Vestergaard A, Aagaard J. Five-year mortality in lithium-treated manic-depressive patients. J Affect Disord 1991;21:33-38.
62. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann NY Acad Sci 1997;836:339-351.
63. Muller-Oerlinghausen B, Wolf T, Ahrens B. Mortality during initial and during later lithium treatment: a collaborative study by the International Group for the Study of Lithium-Treated Patients. Acta Psychiatr Scand 1994;90:295-297.
64. Muller-Oerlinghausen B, Wolf T, Ahrens B. Mortality of patients who dropped out from regular lithium pophylaxis: a collaborative study by the International Group for the Study of Lithium-Treated Patients (IGSLI). Acta Physiologica Scand 1996;94:344-347.
65. Lenz G, Krankenhaus A. Increased mortality after drop-out lithium clinic. Neuropsychopharmacology 1994;10:682S.
66. Nilsson A. Lithium therapy and suicide risk. J Clin Psychiatry 1999;60(suppl 2):85-88.
67. Kallner G, Lindelius R. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry 2000;33:8-13.
68. Bochetta A, Ardau R. Suicidal behavior on and off lithium prophilaxis in a group of patients with prior suicide attempts. J Clin Psychopharmacol 1998;18:384-389.
69. Lepkifker E, Horesh N, Floru S. Long-term lithium prophylaxis in recurrent unipolar depression. Acta Psychiatrica Belgica 1985;85:434-443.
70. Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, Tohen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405-414.
71. Bowden C. Effects on suicidality of divalproex, lithium, and placebo in randomized one-year maintenance treatment of bipolar disorder. ACNP 37th Annual Meeting 1998.
72. Kahn DA, Carpenter D, Doherty JP, Frances A. The expert consensus guideline series: treatment of biopolar disorder. J Clin Psychiatry 1996;57:1-88.
73. Wroblewski BA, Joseph AB, Kupfer J, Kalliel K. Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Injury 1997;11:37-47.
74. Kavoussi RJ, Coccaro EF. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. J Clin Psychiatry 1998;59:676-680.
75. Zayas EM, Grossberg GT. Treating the agitated Alzheimer patient. J Clin Psychiatry 1996;57:46-51.
76. Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. J Am Med Assoc 1992;268:3441-3445.
77. Montgomery SA, McAuley R, Rani SJ, Roy D, Montgomery DB. A double blind comparison of zimelidine and amitriptyline inendogenous depression. Acta Psychiatr Scand 1981;290:314-327.
78. Filteau M-J, Lapierre YD, Bakish D, Blanchard A. Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Psychiatr Neurosci 1993;18:114-119.
79. Mullin JM, Pandita-Gunawardena VR, Whitehead AM. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br J Clin Practice 1988;42:51-55.
80. Gonella G, Baignoli G, Ecari U. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin 1990;12:177-184.
81. Beasley CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey Jr AH, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Br Med J 1991;303:685-692.
82. Montgomery SA, Dunner DL, Dunbar GC. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995;5:5-13.
83. Verkes RJ, Van der Mast RC, Hengeveld MW, Tuyl JP, Zwinderman AH, Van Kempen GMJ. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatry 1998;155:543-547.
84. Rouillon F, Phillips R, Serrurier D, Ansart E, Gérard MJ. Rechutes de dépression unipolaire et efficacité de la maprotiline. L'Encéphale 1989;XV:527-534.
85. Montgomery SA, Montgomery D. Pharmacological prevention of suicidal behaviour. J Affect Disord 1982;4:291-298.
86. Taiminen TJ, Kujari H. Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. A controlled retrospective study. Acta Psychiatr Scand 1994;90:247-251.
87. Pickar D, Roy A, Breier A, Doran A, Wolkowitz O, Colison J, Ågren H. Suicide and aggression in schizophrenia. Neurobiologic correlates. Ann NY Acad Sci 1986;487:189-196.
88. Drake RE, Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry 1985;142(4):499-501.
89. Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995;152:183-190.
90. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin N Am 1997;20:427-450.
91. Prien RF, Klett CJ, Caffey EM. Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 1974;131:198-203.
92. Wickham EA, Reed JV. Lithium for the control of aggressive and self-mutilating behaviour. Int Clin Psychopharm 1987;2:181-190.
93. Sheard MH, Marini JL, Bridges CI, Wagner E. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976; 133:1409-1413.
94. Nordström P, Åsberg M, Aberg-Wistedt A, Nordin C. Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatr Scand 1995;92:345-350.
95. Cooper SJ, Kelly CB, King DJ. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 1992;340:940-941.
96. Arango V, Underwood MD. Serotonin chemistry in the brain of suicide victims, In: Maris R, Silverman M, Canetto S, editors. Review of suicidology. New York: Guilford Press, 1997.